HomeSLDB • NASDAQ
Solid Biosciences Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | -56.54M | -4.12% |
Net income | -42.60M | -109.47% |
Net profit margin | — | — |
Earnings per share | -1.00 | 0.00% |
EBITDA | -39.41M | -78.70% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 148.92M | 20.45% |
Total assets | 188.66M | 14.38% |
Total liabilities | 51.42M | 33.69% |
Total equity | 137.25M | — |
Shares outstanding | 77.49M | — |
Price to book | 1.69 | — |
Return on assets | -49.81% | — |
Return on capital | -56.48% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -42.60M | -109.47% |
Cash from operations | -29.65M | -42.37% |
Cash from investing | 38.57M | -14.86% |
Cash from financing | 6.94M | 1,274.26% |
Net change in cash | 15.86M | -36.50% |
Free cash flow | -13.73M | 1.12% |
Previous close
$5.73
Day range
$5.18 - $5.73
Year range
$2.88 - $15.05
Market cap
208.16M USD
Avg Volume
4.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Website
Employees
100
